<DOC>
	<DOCNO>NCT02461420</DOCNO>
	<brief_summary>The purpose study comprehensively characterize PMS use standardized medical , cognitive , behavioral measure track natural history syndrome use repeat longitudinal assessment . In addition , study aim identify biomarkers use neuroimaging , include difusion tensor image identify genetic factor contribute diverse phenotype patient PMS .</brief_summary>
	<brief_title>Mapping Genotype , Phenotype , Natural History Phelan-McDermid Syndrome</brief_title>
	<detailed_description>Phelan-McDermid syndrome ( PMS ) 22q13 Deletion syndrome , cause loss one copy SHANK3 gene , characterize global developmental delay/intellectual disability , motor skill deficit , delay absent speech , autism spectrum disorder . The goal study understand PMS phenotype biological pathway associate ID ASD disorder , establish foundation future clinical trial PMS ID/ASD-associated disorder share signal pathway PMS . Individuals PMS ask participate study age 3 21 year age pathogenic deletion mutation SHANK3 gene time enrollment . Both male female ask participate . Additionally , eligible study participation , individual ' primary communicative language must English . Parents unaffected sibling may also ask consent blood drawn analysis . The study involve 5 visit ( 3 site visit ) 2 year . Study visit involve physical exam , medical history question , blood work neuropsychological assessment . Individuals certain clinically indicate procedure ( i.e . MRI , EEG , etc . ) due do part research study .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Autism Spectrum Disorder</mesh_term>
	<mesh_term>Child Development Disorders , Pervasive</mesh_term>
	<mesh_term>Intellectual Disability</mesh_term>
	<mesh_term>Chromosome Deletion</mesh_term>
	<mesh_term>Chromosome Disorders</mesh_term>
	<criteria>Individuals 3 21 year age pathogenic deletion mutation SHANK3 gene English speaking individual Individuals young 3 old 21 time enrollment</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Phelan-McDermid Syndrome</keyword>
	<keyword>PMS</keyword>
	<keyword>Genotype</keyword>
	<keyword>Phenotype</keyword>
	<keyword>Natural History</keyword>
	<keyword>Mapping</keyword>
	<keyword>22q13 Deletion Syndrome</keyword>
	<keyword>SHANK3</keyword>
	<keyword>Autism Spectrum Disorder</keyword>
	<keyword>ASD</keyword>
	<keyword>Intellectual Disability</keyword>
	<keyword>ID</keyword>
</DOC>